← Alle mensen

DP

David Pook

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastati...

The Lancet. Oncology · 2025-03

Lu-PSMA-617 plus enzalutamide bij mCRPC: PSMAfore fase III

The Lancet. Oncology · 2024-05

Nivolumab plus cabozantinib versus sunitinib bij gevorderd RCC: CheckMate 9ER fase III

The New England journal of medicine · 4 maart 2021

Nivolumab-ipilimumab versus sunitinib bij mRCC: CheckMate 214 42-maanden update

The Lancet. Oncology · 2019-10